ISC
  • #ISC25
  • Privacy Policy
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Program
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Program
Resources
  • #ISC25
  • Privacy Policy
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon YouTube iconPinterest iconLinkedIn icon
Jun 8th, 2020

Genotype-Guided Dosing of Warfarin in Chinese Adults: A Multicenter Randomized Clinical Trial

Chengxian Guo, Yun Kuang, Honghao Zhou, Hong Yuan, Qi Pei, Jingle Li, Weihong Jiang, Chee M. Ng, Xiaoping Chen, Yong Huo, Yimin Cui, Xiaobin Wang, Jingjing Yu, Xue Sun, Wanying Yu, Peng Chen, Da Miao, Wenyu Liu, Zaixin Yu, Zewei Ouyang, Xiangjiang Shi, Chunmei Lv, Zijing Peng, Guozuo Xiong, Gaofeng Zeng, Jianping Zeng, Haiying Dai, Jianqiang Peng, Yuming Zhang, Fanghua Xu, Jie Wu, Xiaoliang Chen, Hao Gong, Zhiyuan Yang, Xianming Wu, Qiulian Fang, Liu Yang, Haigang Li, Hongyi Tan, Zhijun Huang, Xiaohong Tang, Qiong Yang, Shan Tu, Xiaoyan Wang, Yuxia Xiang, Jie Huang, Xiaomin Wang, Jingjing Cai, Shanjie Jiang, Lu Huang, Jinfu Peng, Liying Gong, Chan Zou, and Guoping Yang
Originally published 8 Jun 2020 | Circulation: Genomic and Precision Medicine

Genotype Guided Dosing 1179992727

Abstract

Background - Warfarin is an effective treatment for thromboembolic disease but has a narrow therapeutic index; optimal anticoagulation dosage can differ tremendously among individuals. We aimed to evaluate whether genotype-guided warfarin dosing is superior to routine clinical dosing for the outcomes of interest in Chinese patients.

Methods - We conducted a multicenter, randomized, single-blind, parallel-controlled trial from September 2014 to April 2017 in 15 hospitals in China. Eligible patients were 18 years or older, with atrial fibrillation or deep vein thrombosis without previous treatment of warfarin or a bleeding disorder. Nine follow-up visits were performed during the 12-week study period. The primary outcome measure was the percentage of time in the therapeutic range (%TTR) of the international normalized ratio (INR) during the first 12 weeks after starting warfarin therapy.

Results - A total of 660 participants were enrolled and randomly assigned to a genotype-guided dosing group or a control group under standard dosing. The genotype-guided dosing group had a significantly higher %TTR than the control group (58.8% vs. 53.2%, 95% confidence interval of group difference (95%CI): 1.1-10.2; P=0.01). The genotype-guided dosing group also achieved the target INR sooner than the control group. In subgroup analyses, warfarin normal sensitivity group had an even higher %TTR during the first 12 weeks compared to the control group (60.8% vs. 48.9%; 95% CI: 1.1-24.4). The incidence of adverse events was low in both groups.

Conclusions - The outcomes of genotype-guided warfarin dosing were superior to those of clinical standard dosing. These findings raise the prospect of precision warfarin treatment in China.


Full text of this article is available at https://www.ahajournals.org/doi/10.1161/CIRCGEN.119.002602

Interesting Stories
NIH Stroke Scale
Sponsored by American Heart Association/American Stroke Association
NIH Stroke Scale
Cholesterol for Professionals
Sponsored by American Heart Association/American Stroke Association
Cholesterol for Professionals
Connection Between Sleep and Cardiovascular Disease
Sponsored by American Heart Association/American Stroke Association
Connection Between Sleep and Cardiovascular Disease
Stroke Risks and Prevention
Sponsored by American Heart Association/American Stroke Association
Stroke Risks and Prevention
More Content
Getty Images 1209679031
archives
Blood Pressure De-Regulation and Renal Function Are Main Determinants of COVID-19 Mortality
Nov 3rd, 2020
Getty Images 635821036 (1)
archives
Paroxysmal Hypertension Associated With Urination
Aug 21st, 2020
Role Of Rare 1179119573
archives
Role of Rare and Low-Frequency Variants in Gene-Alcohol Interactions on Plasma Lipid Levels
Jun 8th, 2020
Alcohol Consumption 1179303998
archives
Alcohol Consumption and Cardiovascular Disease
May 5th, 2020
Maxresdefault 5ec05f63f3ede
archives
Quality Improvement in Rural Settings
Feb 10th, 2020
Maxresdefault 5ebedc02d0306
archives
AHA-ISPOR Joint Session on Real-World Evidence
Feb 10th, 2020
Getty Images 1214643007
archives
Code Blue During the COVID-19 Pandemic
Feb 10th, 2020
Getty Images 1216865680
archives
Navigating Health Care Supply Shortages During the COVID-19 Pandemic
Feb 10th, 2020
Getty Images 1000912070
archives
Role of Data Registries in the Time of COVID-19
Feb 10th, 2020
Getty Images 1132235083
archives
Burden and Consequences of Financial Hardship From Medical Bills Among Nonelderly Adults With Diabetes Mellitus in the United States
Feb 6th, 2020